143 related articles for article (PubMed ID: 34998950)
21. Sudden Death and Left Ventricular Involvement in Arrhythmogenic Cardiomyopathy.
Miles C; Finocchiaro G; Papadakis M; Gray B; Westaby J; Ensam B; Basu J; Parry-Williams G; Papatheodorou E; Paterson C; Malhotra A; Robertus JL; Ware JS; Cook SA; Asimaki A; Witney A; Ster IC; Tome M; Sharma S; Behr ER; Sheppard MN
Circulation; 2019 Apr; 139(15):1786-1797. PubMed ID: 30700137
[TBL] [Abstract][Full Text] [Related]
22. [Arrhythmogenic cardiomyopathy. Patterns of ventricular involvement using cardiac magnetic resonance].
Igual B; Zorio E; Maceira A; Estornell J; Lopez-Lereu MP; Monmeneu JV; Quesada A; Navarro J; Mas F; Salvador A
Rev Esp Cardiol; 2011 Dec; 64(12):1114-22. PubMed ID: 22030343
[TBL] [Abstract][Full Text] [Related]
23. Clinical Findings and Diagnostic Yield of Arrhythmogenic Cardiomyopathy Through Genomic Screening of Pathogenic or Likely Pathogenic Desmosome Gene Variants.
Carruth ED; Beer D; Alsaid A; Schwartz MLB; McMinn M; Kelly MA; Buchanan AH; Nevius CD; Calkins H; James CA; Murray B; Tichnell C; Matsumura ME; Kirchner HL; Fornwalt BK; Sturm AC; Haggerty CM
Circ Genom Precis Med; 2021 Apr; 14(2):e003302. PubMed ID: 33684294
[TBL] [Abstract][Full Text] [Related]
24. Subcutaneous implantable cardioverter defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy: Results from an Italian multicenter registry.
Migliore F; Viani S; Bongiorni MG; Zorzi A; Silvetti MS; Francia P; D'Onofrio A; De Franceschi P; Sala S; Donzelli S; Ricciardi G; Menardi E; Giammaria M; La Greca C; Bauce B; Rigato I; Iliceto S; Bertaglia E; Diemberger I; Corrado D
Int J Cardiol; 2019 Apr; 280():74-79. PubMed ID: 30661851
[TBL] [Abstract][Full Text] [Related]
25. Association of regional epicardial right ventricular electrogram voltage amplitude and late gadolinium enhancement distribution on cardiac magnetic resonance in patients with arrhythmogenic right ventricular cardiomyopathy: Implications for ventricular tachycardia ablation.
Xie S; Desjardins B; Kubala M; Liang J; Yang J; van der Geest RJ; Schaller R; Riley M; Callans D; Zado E; Marchlinski F; Nazarian S
Heart Rhythm; 2018 Jul; 15(7):987-993. PubMed ID: 29501666
[TBL] [Abstract][Full Text] [Related]
26. Phenotypic analysis of arrhythmogenic cardiomyopathy in the Hutterite population: role of electrocardiogram in identifying high-risk desmocollin-2 carriers.
Wong JA; Duff HJ; Yuen T; Kolman L; Exner DV; Weeks SG; Gerull B
J Am Heart Assoc; 2014 Dec; 3(6):e001407. PubMed ID: 25497880
[TBL] [Abstract][Full Text] [Related]
27. Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers.
James CA; Bhonsale A; Tichnell C; Murray B; Russell SD; Tandri H; Tedford RJ; Judge DP; Calkins H
J Am Coll Cardiol; 2013 Oct; 62(14):1290-1297. PubMed ID: 23871885
[TBL] [Abstract][Full Text] [Related]
28. Arrhythmogenic Cardiomyopathy in 2018-2019: ARVC/ALVC or Both?
Bennett RG; Haqqani HM; Berruezo A; Della Bella P; Marchlinski FE; Hsu CJ; Kumar S
Heart Lung Circ; 2019 Jan; 28(1):164-177. PubMed ID: 30446243
[TBL] [Abstract][Full Text] [Related]
29. Diagnosing ARVC in Pediatric Patients Applying the Revised Task Force Criteria: Importance of Imaging, 12-Lead ECG, and Genetics.
Steinmetz M; Krause U; Lauerer P; Konietschke F; Aguayo R; Ritter CO; Schuster A; Lotz J; Paul T; Staab W
Pediatr Cardiol; 2018 Aug; 39(6):1156-1164. PubMed ID: 29754204
[TBL] [Abstract][Full Text] [Related]
30. Myocardial fibrosis in arrhythmogenic cardiomyopathy: a genotype-phenotype correlation study.
Segura-Rodríguez D; Bermúdez-Jiménez FJ; Carriel V; López-Fernández S; González-Molina M; Oyonarte Ramírez JM; Fernández-Navarro L; García-Roa MD; Cabrerizo EM; Durand-Herrera D; Alaminos M; Campos A; Macías R; Álvarez M; Tercedor L; Jiménez-Jáimez J
Eur Heart J Cardiovasc Imaging; 2020 Apr; 21(4):378-386. PubMed ID: 31702781
[TBL] [Abstract][Full Text] [Related]
31. Value of the signal-averaged electrocardiogram in arrhythmogenic right ventricular cardiomyopathy/dysplasia.
Kamath GS; Zareba W; Delaney J; Koneru JN; McKenna W; Gear K; Polonsky S; Sherrill D; Bluemke D; Marcus F; Steinberg JS
Heart Rhythm; 2011 Feb; 8(2):256-62. PubMed ID: 20933608
[TBL] [Abstract][Full Text] [Related]
32. Arrhythmogenic Right Ventricular Cardiomyopathy: Characterization of Left Ventricular Phenotype and Differential Diagnosis With Dilated Cardiomyopathy.
Cipriani A; Bauce B; De Lazzari M; Rigato I; Bariani R; Meneghin S; Pilichou K; Motta R; Aliberti C; Thiene G; McKenna WJ; Zorzi A; Iliceto S; Basso C; Perazzolo Marra M; Corrado D
J Am Heart Assoc; 2020 Mar; 9(5):e014628. PubMed ID: 32114891
[TBL] [Abstract][Full Text] [Related]
33. Comparison of patients with early-phase arrhythmogenic right ventricular cardiomyopathy and right ventricular outflow tract ventricular tachycardia.
Saberniak J; Leren IS; Haland TF; Beitnes JO; Hopp E; Borgquist R; Edvardsen T; Haugaa KH
Eur Heart J Cardiovasc Imaging; 2017 Jan; 18(1):62-69. PubMed ID: 26903598
[TBL] [Abstract][Full Text] [Related]
34. Clinical Differentiation Between Physiological Remodeling and Arrhythmogenic Right Ventricular Cardiomyopathy in Athletes With Marked Electrocardiographic Repolarization Anomalies.
Zaidi A; Sheikh N; Jongman JK; Gati S; Panoulas VF; Carr-White G; Papadakis M; Sharma R; Behr ER; Sharma S
J Am Coll Cardiol; 2015 Jun; 65(25):2702-11. PubMed ID: 26112193
[TBL] [Abstract][Full Text] [Related]
35. Utility of ECG-gated MDCT to differentiate patients with ARVC/D from patients with ventricular tachyarrhythmias.
Nakajima T; Kimura F; Kajimoto K; Kasanuki H; Hagiwara N
J Cardiovasc Comput Tomogr; 2013; 7(4):223-33. PubMed ID: 23992839
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of atrial arrhythmias in arrhythmogenic right ventricular dysplasia/cardiomyopathy.
Camm CF; James CA; Tichnell C; Murray B; Bhonsale A; te Riele AS; Judge DP; Tandri H; Calkins H
Heart Rhythm; 2013 Nov; 10(11):1661-8. PubMed ID: 23994726
[TBL] [Abstract][Full Text] [Related]
37. Left ventricular involvement assessed by LGE-CMR in predicting the risk of adverse outcomes of arrhythmogenic cardiomyopathy with ICDs.
Zhang N; Song Y; Hua W; Hu Y; Chen L; Cai M; Niu H; Cai C; Gu M; Zhao S; Zhang S
Int J Cardiol; 2021 Aug; 337():79-85. PubMed ID: 33839174
[TBL] [Abstract][Full Text] [Related]
38. Clinical and genetic characterization of families with arrhythmogenic right ventricular dysplasia/cardiomyopathy provides novel insights into patterns of disease expression.
Sen-Chowdhry S; Syrris P; Ward D; Asimaki A; Sevdalis E; McKenna WJ
Circulation; 2007 Apr; 115(13):1710-20. PubMed ID: 17372169
[TBL] [Abstract][Full Text] [Related]
39. Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy.
Rubinshtein R; Glockner JF; Ommen SR; Araoz PA; Ackerman MJ; Sorajja P; Bos JM; Tajik AJ; Valeti US; Nishimura RA; Gersh BJ
Circ Heart Fail; 2010 Jan; 3(1):51-8. PubMed ID: 19850699
[TBL] [Abstract][Full Text] [Related]
40. Novel mutation in desmoplakin causes arrhythmogenic left ventricular cardiomyopathy.
Norman M; Simpson M; Mogensen J; Shaw A; Hughes S; Syrris P; Sen-Chowdhry S; Rowland E; Crosby A; McKenna WJ
Circulation; 2005 Aug; 112(5):636-42. PubMed ID: 16061754
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
